Lonza-Capsugel-Header

Lonza-Capsugel-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Neuraxpharm

Development, Manufacturing & Marketing of Pharmaceuticals for Central Nervous System Pathologies.

Contact Supplier

Contact Supplier

Digital Content

CPhI Worldwide 2021

Alpha Meeting Room: Hall 3

Request a Meeting Now

Permira Funds to Acquire Leading European CNS Specialty Pharmaceutical Company Neurax...

Lead Product(s): Undisclosed

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Approved Product Type: Undisclosed

Partner/Sponsor/Collaborator: Permira Funds

Deal Size: $1,880.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition September 22, 2020

Details:

The Permira funds will support the management’s vision of becoming the leading CNS-focused specialty pharmaceutical platform in Europe through driving the commercializa